 Bicycle Therapeutics plc NASDAQ: BCYC, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide Bicycle technology, today announced the appointment of Sir Keith Peters FRS as Chairman of the Companys Scientific Advisory Board SAB. 